PDCD1 and non-small cell lung carcinoma: Furthermore, corrC2 is the only panel predicting resistance to PD1 blockade therapy at AUC 0.8 in the “Ruppin2021_PD1_NSCLC” dataset (Additional file 18: Fig S18).